Could a cheap epilepsy drug boost brain power in kids with rare syndrome?
NCT ID NCT01619644
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study tested whether sodium valproate, a drug used for epilepsy, could improve memory and motor skills in children with Rubinstein-Taybi syndrome (RTS). 41 children aged 6 to 21 with confirmed RTS were randomly given either the drug or a placebo for one year. The goal was to see if the drug could help with learning, memory, and fine motor control, using tests, brain scans, and blood work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RUBINSTEIN-TAYBI SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Bordeaux, France
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.